February 05, 2026

Putting a POC Troponin to the Test

Independent verification shows strong precision and concordance with lab assays across clinical thresholds.

Conexiant

February 04, 2026

Plasma pTau217 Cutoffs for Clinical Use

Researchers assess how biological factors influence plasma biomarker interpretation for amyloid detection.

Conexiant

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

January 21, 2026

$3M Gene Therapy—With a Catch

Medicaid is testing a pay-for-performance deal that makes drugmakers refund millions if new sickle cell gene therapies fail.

KFF Health News

January 12, 2026

Atypical Meningococcemia: Diagnostic Lessons From a Fatal Case

A fatal NEJM case highlights how invasive meningococcal disease—particularly serogroup W—can present without rash, masquerade as gastrointestinal illness, and rapidly progress to shock and DIC.

Conexiant

January 09, 2026

Rethinking D-Dimer with Age in Mind

JAMA study shows age-adjusted cutoffs safely exclude DVT in more patients, sparing unnecessary ultrasounds

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

February 12, 2025

FDA & EMA: Submitted Trial Data Discrepancies

Sample size discrepancies were identified in 13 trials (65%), with 8 differing by more than 10%.

Conexiant